Showing results (21-30 of 409) with videos related to
Sort By:
Pageof 41
The Lancet. Diabetes & Endocrinology|March 14, 2014
Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trialWenying Yang, Jie Liu, Zhongyan Shan, et al.Frontiers in Immunology|July 22, 2022
Endothelial Cells as a Key Cell Type for Innate Immunity: A Focused Review on RIG-I Signaling PathwaySuowen Xu, Tengchuan Jin, Jianping WengJournal of Diabetes Investigation|July 15, 2022
Hyperglycemia-mediated oocyte TET3 insufficiency predisposes offspring to glucose intoleranceXiumei Wu, Suowen Xu, Jianping WengScience China. Life Sciences|September 30, 2018
A thorough analysis of diabetes research in China from 1995 to 2015: current scenario and future scopeZekai Wu, Tianru Jin, Jianping WengTrends in Molecular Medicine|June 14, 2022
Marijuana and endothelial dysfunction: new mechanism and therapyXiaojun Feng, Suowen Xu, Jianping WengJournal of Affective Disorders|August 14, 2013
Measuring depressive symptoms using the Patient Health Questionnaire-9 in Hong Kong Chinese subjects with type 2 diabetesYuying Zhang, Rose Ting, Marco Lam, et al.Journal of Diabetes Science and Technology|November 30, 2016
Impact of HbA1c Testing at Point of Care on Diabetes ManagementOliver Schnell, J Benjamin Crocker, Jianping WengPlos One|June 19, 2013
Prevalence of hypertension in china: a cross-sectional studyYun Gao, Gang Chen, Haoming Tian, et al.Endocrine Journal|September 10, 2020
Gender-differential effects on blood glucose levels between acarbose and metformin in Chinese patients with newly diagnosed type 2 diabetes: a sub-analysis of the MARCH trialJianxin Li, Jing Li, Zhongyan Shan, et al.Journal of Obesity|July 20, 2012
Weight loss is still an essential intervention in obesity and its complications: a reviewJianzhong Xiao, Wenying YangPageof 41